NCT05435495 2026-03-18
Mechanisms of Resistance to PSMA Radioligand Therapy
University of California, San Francisco
Recruiting
Clinical Trials
24 trialsNCT06960798 2026-03-02
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
University of Oklahoma
Recruiting
NCT02657863 2025-12-23
Cancer DNA Detection in Blood and Urine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT02869282 2025-09-17
CHEMOPROST
Institut Bergonié
Withdrawn
NCT05819827 2025-04-27
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Terminated
NCT06509919 2024-12-27
Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer
Shanghai Changzheng Hospital
Recruiting
NCT03558048 2024-04-24
The Effect of IBD Flares on Serum PSA
Northwestern University
Recruiting
NCT06260410 2024-04-22
LUTRAC
Erasmus Medical Center
Recruiting
NCT05415787 2024-03-01
PROMECI
University Hospital, Tours
Completed
NCT03871816 2023-12-11
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Janssen Research & Development, LLC
Completed
NCT06116851 2023-11-03
PROMIC
Turku University Hospital
Recruiting
NCT02070575 2023-10-23
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence
Memorial Sloan Kettering Cancer Center
Completed
NCT05437679 2023-09-05
CHARTER
Angle plc
Terminated
NCT03381326 2023-06-02
IRSTB030
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Unknown
NCT02376296 2022-02-17
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Saladax Biomedical, Inc.
Completed
NCT03816904 2021-04-28
NEUROTAX
University Hospital, Tours
Completed
NCT04746300 2021-02-09
PROMPT
Radboud University Medical Center
Unknown
NCT01414712 2020-08-20
Circulating Tumor Cells in Prostate Cancer Patients
University of Texas Southwestern Medical Center
Terminated
NCT02771769 2020-01-18
Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels
Chronix Biomedical Corporation
Terminated
NCT03228810 2019-05-09
Genetic Biomarker Discovery for Metastatic Prostate Cancer
Mayo Clinic
Completed
NCT02742259 2019-03-26
VPCA-B+PIV
Celsee Diagnostics
Withdrawn
NCT02940977 2018-07-10
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Unknown
NCT01528774 2017-07-26
CTC
Comprehensive Cancer Centers of Nevada
Completed
NCT02723526 2016-03-31
Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer
Fudan University
Unknown